Raia Drogasil Valuation
| RADLY Stock | USD 4.42 0.27 6.51% |
At this time, the company appears to be overvalued. Raia Drogasil SA holds a recent Real Value of $3.7 per share. The prevailing price of the company is $4.42. Our model determines the value of Raia Drogasil SA from analyzing the company fundamentals such as Shares Outstanding of 1.65 B, operating margin of 0.06 %, and Return On Equity of 0.18 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Raia Drogasil's price fluctuation is very risky at this time. Calculation of the real value of Raia Drogasil SA is based on 3 months time horizon. Increasing Raia Drogasil's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Raia Drogasil is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Raia Pink Sheet. However, Raia Drogasil's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.42 | Real 3.7 | Hype 4.42 | Naive 4.13 |
The intrinsic value of Raia Drogasil's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Raia Drogasil's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Raia Drogasil SA helps investors to forecast how Raia pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Raia Drogasil more accurately as focusing exclusively on Raia Drogasil's fundamentals will not take into account other important factors: Raia Drogasil Total Value Analysis
Raia Drogasil SA is at this time expected to have takeover price of 8.48 B with market capitalization of 20.08 B, debt of 891.39 M, and cash on hands of 818.81 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Raia Drogasil fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.48 B | 20.08 B | 891.39 M | 818.81 M |
Raia Drogasil Investor Information
The company last dividend was issued on the 23rd of December 2022. Raia Drogasil SA had 5:1 split on the 1st of October 2020. Raia Drogasil SA is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Raia Drogasil Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Raia Drogasil has an asset utilization ratio of 163.29 percent. This suggests that the Company is making $1.63 for each dollar of assets. An increasing asset utilization means that Raia Drogasil SA is more efficient with each dollar of assets it utilizes for everyday operations.Raia Drogasil Ownership Allocation
Raia Drogasil owns a total of 1.65 Billion outstanding shares. Roughly 99.98 pct. of Raia Drogasil outstanding shares are held by general public with 0.022 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Raia Drogasil Profitability Analysis
The company reported the revenue of 24.13 B. Net Income was 751.93 M with profit before overhead, payroll, taxes, and interest of 7.21 B.About Raia Drogasil Valuation
Our relative valuation model uses a comparative analysis of Raia Drogasil. We calculate exposure to Raia Drogasil's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Raia Drogasil's related companies.Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. The company was founded in 1905 and is headquartered in So Paulo, Brazil. RAIA DROGASIL operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 50320 people.
8 Steps to conduct Raia Drogasil's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Raia Drogasil's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Raia Drogasil's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Raia Drogasil's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Raia Drogasil's revenue streams: Identify Raia Drogasil's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Raia Drogasil's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Raia Drogasil's growth potential: Evaluate Raia Drogasil's management, business model, and growth potential.
- Determine Raia Drogasil's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Raia Drogasil's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Raia Drogasil Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.6 B | |
| Quarterly Earnings Growth Y O Y | 0.394 | |
| Forward Price Earnings | 28.49 | |
| Retained Earnings | 2.1 B |
Additional Tools for Raia Pink Sheet Analysis
When running Raia Drogasil's price analysis, check to measure Raia Drogasil's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raia Drogasil is operating at the current time. Most of Raia Drogasil's value examination focuses on studying past and present price action to predict the probability of Raia Drogasil's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raia Drogasil's price. Additionally, you may evaluate how the addition of Raia Drogasil to your portfolios can decrease your overall portfolio volatility.